Table 4.
Estimated price differential between equally cost effective bivalent and quadrivalent human papillomavirus vaccines (vaccination of girls aged 12 years, 80% effective vaccine coverage, 100 year time horizon, and 3.5% discount rate for costs and benefits)
| Age at vaccination and catch-up | Duration of vaccine protection | ||
|---|---|---|---|
| 10 years | 20 years | Life long | |
| Girls aged 12 only: | |||
| Median (£) | 12.96 | 17.27 | 20.94 |
| 95% centile (£) | 22.06 | 26.59 | 30.30 |
| 5% centile (£) | 6.26 | 9.37 | 12.95 |
| Girls aged 12 with catch-up to age 18: | |||
| Median (£) | 15.54 | 20.28 | 23.21 |
| 95% centile (£) | 25.26 | 29.91 | 32.79 |
| 5% centile (£) | 8.58 | 12.28 | 14.98 |
£1.00 (€1.26; $1.98).
Results are based on 50 000 meta-scenarios representing uncertainty in epidemiological and economic parameters.